News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Link Technologies Ltd to Present Poster at Cambridge Symposium on Nucleic Acids

8/25/2011 10:44:28 AM

BELLSHILL, SCOTLAND, 25 August 2011: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, will exhibit and present a poster at this year’s Cambridge Symposium on Nucleic Acids Chemistry and Biology (CSNACB), Cambridge, UK (4-7 September 2011). Entitled ‘Tocopherol (Vitamin E) Modified Oligonucleotides’, the new poster builds on previous findings generated by the scientists at Link Technologies and describes the use of the vitamin tocopherol to improve the purification of thiol-modified oligos. Thiol-modification is often used as a means of incorporating labels such as dyes and other active compounds directly into oligos, the likes of which have a range of applications such as in diagnostics research.

Link Technologies supplies reagents for oligo synthesis and modification, with a focus on quality, flexibility and responsiveness. An ISO 9001:2008 certified quality management system, rigorous quality control (QC) procedures and pro-active delivery tracking all help to maximise accuracy and efficiency. In stock items are shipped-same day and all enquiries are dealt with in less than 24hrs, while a fully bespoke custom synthesis service and flexible QC options complement the extensive product catalogue to rapidly and reliably meet the individual needs of each customer. To learn more about the solutions offered by Link Technologies visit the stand at CSNACB. Alternatively, follow @linktechdna on Twitter for all the latest news from the show and beyond. More information can also be found by reading the latest Link Technologies blog post.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.

Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see:

Read at

comments powered by Disqus